CECOG Academy

www.cecog.org

 

CECOG Academy
C

New Adjuvant Therapies for eBC: Olaparib & Talazoparib for BRCA Mutations

By CECOG Academy FEATURING Christian Singer
By CECOG Academy FEATURING Christian Singer
110 views
April 1, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

03:15
Lilly Medical Affairs

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse
Post ESMO Webinar
11:47

Adjuvant Therapies for HER2+ eBC: Trastuzumab & Pertuzumab, T-DM1 & …

CECOG Academy

C. Singer

58 views
14:05

New Adjuvant Therapies for eBC: Olaparib & Talazoparib for BRCA Muta…

CECOG Academy

C. Singer

110 views
29:38

monarchE vs. PALLAS Data on Adjuvant ET in HR+ EBC: What Makes the C…

CECOG Academy

A. Awada

637 views
22:11

How to Increase the Efficacy of Antiendocrine Treatment of BC: Optio…

CECOG Academy

P. Fasching

53 views
22:31

Immune Checkpoint Inhibition in mBC: Does the Chemotherapy Backbone …

CECOG Academy

R. Bartsch

13 views